NovaBridge Biosciences (NBP)

Name: NovaBridge Biosciences (NBP) annual fundamentals
Creator: TickerFacts
License: https://creativecommons.org/publicdomain/zero/1.0/

Build a valuation ↗↓ Download CSV

CIK 0001778016 · Nasdaq · Pharmaceutical Preparations

Sector Manufacturing
Fiscal year ends Dec 31

For the year ended 2023-12-31, NovaBridge Biosciences reported revenue of 27.64M CNY.

Key ratios (year ended 2023-12-31)

n/m

Net margin

-85.3%

Return on year-end equity

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 4 (ownership change) · 2026-10-19

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

Period ended	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2010-12-31
Revenue	n/a	n/a	27.64M CNY	-221.56M CNY	88.03M CNY	1.54B CNY	30.00M CNY	53.78M CNY	11.56M CNY	n/a
Cost of Revenue	n/a	n/a	n/a	27.24M CNY	46.43M CNY	0 CNY	0 CNY	n/a	n/a	n/a
Gross Profit (computed)	n/a	n/a	n/a	-248.80M CNY	41.59M CNY	n/a	n/a	n/a	n/a	n/a
R&D Expense	n/a	n/a	810.65M CNY	904.90M CNY	1.21B CNY	984.69M CNY	840.41M CNY	426.03M CNY	267.07M CNY	43.60M CNY
Depreciation & Amortization	n/a	n/a	23.90M CNY	25.30M CNY	13.80M CNY	12.70M CNY	9.80M CNY	6.70M CNY	1.60M CNY	n/a
Net Income	n/a	n/a	-1.47B CNY	-2.51B CNY	-2.33B CNY	470.92M CNY	-1.45B CNY	-402.83M CNY	-298.24M CNY	n/a
EPS (Diluted)	n/a	n/a	-7.66 CNY	-13.21 CNY	-13.35 CNY	3.00 CNY	-201.19 CNY	-61.70 CNY	-51.93 CNY	n/a
Total Assets	n/a	n/a	2.61B CNY	4.07B CNY	5.60B CNY	6.33B CNY	1.74B CNY	2.38B CNY	n/a	n/a
Total Liabilities	n/a	n/a	894.81M CNY	1.16B CNY	1.04B CNY	706.65M CNY	668.09M CNY	415.68M CNY	n/a	n/a
Shareholders' Equity	n/a	n/a	1.72B CNY	2.91B CNY	4.56B CNY	5.63B CNY	-2.03B CNY	-955.10M CNY	-299.80M CNY	n/a
Cash & Equivalents	n/a	n/a	2.14B CNY	3.21B CNY	3.52B CNY	4.76B CNY	1.14B CNY	1.59B CNY	n/a	n/a
Operating Cash Flow	n/a	n/a	-1.30B CNY	-1.10B CNY	-973.09M CNY	433.56M CNY	-867.98M CNY	-280.70M CNY	-252.16M CNY	n/a
Capital Expenditures	n/a	n/a	11.35M CNY	45.83M CNY	29.93M CNY	8.01M CNY	12.24M CNY	14.41M CNY	20.33M CNY	n/a
Free Cash Flow	n/a	n/a	-1.32B CNY	-1.15B CNY	-1.00B CNY	425.55M CNY	-880.22M CNY	-295.11M CNY	-272.48M CNY	n/a
Shares Outstanding	265.38M	187.45M	185.61M	190.88M	183.83M	164.89M	8.36M	8.36M	n/a	n/a
Weighted Average Diluted Shares	220.26M	186.73M	191.42M	189.79M	174.71M	157.23M	7.38M	6.53M	5.74M	n/a
EPS (Basic)	n/a	n/a	-7.66 CNY	-13.21 CNY	-13.35 CNY	3.51 CNY	-201.19 CNY	-61.70 CNY	-51.93 CNY	n/a

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView